デフォルト表紙
市場調査レポート
商品コード
1533589

神経血管デバイスの市場規模、シェア、成長分析:製品別、疾患病態別、プロセス別、治療用途別、最終用途別 - 産業予測、2024年~2031年

Neurovascular Devices Market Size, Share, Growth Analysis, By Product, By Disease Pathology(Aneurysm, Arteriovenous Malformation and Fistulas ), By Process, By Therapeutic Applications, By End-Use - Industry Forecast 2024-2031

出版日: | 発行: SkyQuest | ページ情報: 英文 157 Pages | 納期: 3~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.12円
神経血管デバイスの市場規模、シェア、成長分析:製品別、疾患病態別、プロセス別、治療用途別、最終用途別 - 産業予測、2024年~2031年
出版日: 2024年08月03日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の神経血管デバイスの市場規模は、2022年に29億米ドルとなり、2023年の31億5,000万米ドルから、2031年までには60億4,000万米ドルに成長し、予測期間(2024年~2031年)のCAGRは8.5%で成長する見通しです。

神経血管デバイス市場は、いくつかの重要な要因によって大きな成長を遂げようとしています。神経疾患の罹患率の上昇、継続的な技術の進歩、低侵襲手技に対する需要の高まりが、この拡大の中心となっています。さらに、主要市場における神経疾患を患う患者数の増加が、神経血管デバイスに対する需要の高まりにつながっています。マーケット成長の主要な触媒は、急性虚血性脳卒中の高い有病率であり、これは効果的な神経血管ソリューションの必要性を強調しています。同市場はまた、迅速な製品承認に加え、先進技術を搭載した新製品発売の急増からも恩恵を受けると予想されます。しかし、厳しい規制の枠組み、特に米国のFDA規制は、これらの機器が厳格な安全性と有効性の基準を満たすことを保証するものであり、開発コストは上昇するものの、最終的には患者ケアの質を高めることになります。新しい塞栓装置、血栓除去システム、高度なマイクロカテーテルのイントロダクションを含む神経血管デバイスにおける絶え間ない技術革新が、市場の成長をさらに後押ししています。Medtronic、Stryker、Penumbraなどの大手企業が最先端製品や技術の進歩で市場を促進しています。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主要な市場の考察

  • 技術分析
  • ケーススタディ分析
  • 価格分析
  • バリューチェーン分析
  • 特許分析
  • 貿易分析
  • 顧客と購買基準の分析
  • 市場のエコシステム
  • スタートアップ分析
  • 規制情勢
  • イノベーションマトリクス
  • 主要な投資分析
  • 主要な成功要因
  • 競合の程度

神経血管デバイス市場:疾患病態別

  • 市場概要
  • 脳動脈瘤
    • 塞栓コイル
  • 取り外し可能な裸コイル
  • コーティングされた取り外し可能なコイル
    • 流量転換装置
    • 頭蓋内ステント
    • マイクロカテーテル
    • ガイドワイヤー
  • 虚血性脳卒中
    • 血栓除去装置
    • 吸引・吸引装置
    • 血管スネア
    • マイクロカテーテル
    • マイクロガイドワイヤー
    • バルーンカテーテル
  • 頸動脈狭窄
    • 頸動脈ステント
    • 塞栓保護デバイス
    • バルーンカテーテル
  • 動静脈奇形および瘻孔
    • 液体塞栓剤
    • 閉塞バルーンカテーテル
    • マイクロカテーテル
  • その他の疾患

神経血管デバイス市場:エンドユーザー別

  • 市場概要
  • 病院・外科センター
  • 外来診療センター
  • 研究室・学術機関

神経血管デバイス市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Acandis GmbH(Germany)
  • Asahi Intecc Co. Ltd.(Japan)
  • Imperative Care Inc.(United States)
  • Integer Holdings Corporation(United States)
  • Johnson & Johnson(United States)
  • Medtronic plc(Ireland)
  • MicroPort Scientific Corporation(China)
  • Penumbra Inc.(United States)
  • Perflow Medical Ltd.(Israel)
  • Rapid Medical(Canada)
  • Stryker Corporation(United States)
  • Terumo Corporation(Japan)
  • WL Gore & Associates(United States)
  • Penumbra, Inc.(United States)(duplicate)
  • Silk Road Medical(United States)
  • Siemens Healthineers AG(Germany)
  • Le Maire Vascular(France)
  • Boston Scientific Corporation(United States)
  • Balt(Switzerland)
  • InspireMD, Inc.(Israel)
目次
Product Code: SQMIG35A2777

Global Neurovascular Devices Market size was valued at USD 2.90 Billion in 2022 and is poised to grow from USD 3.15 Billion in 2023 to USD 6.04 Billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031).

The neurovascular devices market is set for significant growth, driven by several key factors. The rising incidence of neurological disorders, ongoing technological advancements, and the growing demand for minimally invasive procedures are central to this expansion. Additionally, the increasing number of patients suffering from neurological conditions in major markets has led to a heightened demand for neurovascular devices. A key catalyst for market growth is the high prevalence of acute ischemic stroke, which underscores the need for effective neurovascular solutions. The market is also expected to benefit from the surge in new product launches featuring advanced technologies, alongside rapid product approvals. However, the stringent regulatory frameworks, particularly the FDA regulations in the United States, ensure that these devices meet rigorous safety and efficacy standards, which can elevate development costs but ultimately enhance patient care quality. Continuous innovation in neurovascular devices, including the introduction of new embolization devices, thrombectomy systems, and advanced microcatheters, is further fueling market growth. Leading companies like Medtronic, Stryker, and Penumbra are at the forefront, driving the market with their cutting-edge products and technological advancements.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurovascular Devices Market Segmental Analysis

The Neurovascular Devices Market is segmented into Disease Pathology, End-User and Region. Based on Disease Pathology, the market is segmented into Cerebral Aneurysm (Embolic Coils [Bare Detachable Coils, Coated Detachable Coils], Flow Diversion Devices, Intracranial Stents, Microcatheters, Guidewires), Arteriovenous Malformation And Fistulas (Liquid Embolic Agents, Occlusion Balloon Catheters, Microcatheters), Ischemic Stroke (Clot Retriever Devices, Suction & Aspiration Devices, Vascular Snares, Microcatheters, Micro Guidewires, Balloon Catheters), Carotid Artery Stenosis (Carotid Artery Stents, Embolic Protection Devices, Balloon Catheters), and Others. Based on End-User, the market is trifurcated into, Hospitals and Surgical Centers, Ambulatory Care Centers, Research Laboratories and Academic Institutes. Based on Region the market is segmented as, North America, Europe, Asia-Pacific, LAMEA, and the Middle East and Africa.

Drivers of the Global Neurovascular Devices Market

The growing preference for minimally invasive surgeries is largely due to their significant benefits, such as lower risks and reduced trauma compared to traditional procedures. These surgeries involve smaller incisions, which lead to less postoperative pain and quicker recovery times. This has significantly driven the adoption of minimally invasive techniques and spurred extensive research and development efforts in the field. Leading industry players are investing heavily in developing innovative surgical instruments to advance minimally invasive procedures.

Restraints in the Global Neurovascular Devices Market

Integrating new neurovascular devices into existing medical infrastructure can be challenging and time-consuming. Often, these devices are not fully compatible with current equipment and electronic health record (EHR) systems used in many hospitals. This integration challenge requires substantial time and resources, potentially delaying the deployment of new technologies and increasing costs.

Market Trends of the Global Neurovascular Devices Market

Globally, the rise in minimally invasive surgeries is driven by their aesthetic benefits, such as shorter recovery times, which is expected to further boost the neurovascular devices market. This growth is largely attributed to advancements in innovation and ongoing improvements within surgical techniques, aimed at enhancing patient safety. Developments in laparoscopic and endoscopic procedures, as well as the introduction of robotic surgeries, signify a shift towards more sophisticated techniques. This trend creates a favorable market environment conducive to the continued progress of the neurovascular devices industry.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Case Study Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • Patent Analysis
  • Trade Analysis
  • Customer & Buying Criteria Analysis
  • Ecosystem of the Market
  • Start-up Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Global Neurovascular Devices Market by Disease Pathology

  • Market Overview
  • Cerebral aneurysms
    • Embolic coils
  • Bare detachable coils
  • Coated detachable coils
    • Flow diversion devices
    • Intracranial stents
    • Microcatheters
    • Guidewires
  • Ischemic strokes
    • Clot retriever devices
    • Suction & aspiration devices
    • Vascular snares
    • Microcatheters
    • Micro guidewires
    • Balloon catheters
  • Carotid artery stenosis
    • Carotid artery stents
    • Embolic protection devices
    • Balloon catheters
  • Arteriovenous malformation & fistulas
    • Liquid embolic agents
    • Occlusion balloon catheters
    • Microcatheters
  • Other disease pathologies

Global Neurovascular Devices Market by End-user

  • Market Overview
  • Hospitals and surgical centres
  • Ambulatory care centres
  • Research laboratories and academic institutes

Global Neurovascular Devices Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Acandis GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Asahi Intecc Co. Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Imperative Care Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integer Holdings Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Penumbra Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perflow Medical Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rapid Medical (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WL Gore & Associates (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Penumbra, Inc. (United States) (duplicate)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Silk Road Medical (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Le Maire Vascular (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Balt (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InspireMD, Inc. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments